Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Goodwill (2016 - 2025)

Avanos Medical (AVNS) has disclosed Goodwill for 13 consecutive years, with $394.9 million as the latest value for Q4 2025.

  • Quarterly Goodwill fell 13.32% to $394.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $394.9 million through Dec 2025, down 13.32% year-over-year, with the annual reading at $394.9 million for FY2025, 13.32% down from the prior year.
  • Goodwill hit $394.9 million in Q4 2025 for Avanos Medical, roughly flat from $394.4 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $826.0 million in Q1 2022 to a low of $381.2 million in Q2 2025.
  • Historically, Goodwill has averaged $701.1 million across 5 years, with a median of $794.6 million in 2024.
  • Biggest five-year swings in Goodwill: increased 4.71% in 2023 and later plummeted 52.01% in 2025.
  • Year by year, Goodwill stood at $742.5 million in 2021, then grew by 2.4% to $760.3 million in 2022, then rose by 4.71% to $796.1 million in 2023, then crashed by 42.77% to $455.6 million in 2024, then decreased by 13.32% to $394.9 million in 2025.
  • Business Quant data shows Goodwill for AVNS at $394.9 million in Q4 2025, $394.4 million in Q3 2025, and $381.2 million in Q2 2025.